Page last updated: 2024-12-08
chlorsuperlutin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
chlorsuperlutin: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 175513 |
CHEMBL ID | 3276150 |
MeSH ID | M0055336 |
Synonyms (16)
Synonym |
---|
17alpha-acetoxy-6-chlor-16-methylen-6-dehydroprogesteron |
pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-chloro-16-methylene- |
17-acetoxy-6-chloro-16-methylene-4,6-pregnadiene-3,20-dione |
sch 12600 |
pregna-4,6-diene-3,20-dione, 6-chloro-17-hydroxy-16-methylene-, acetate |
chlorsuperlutin |
6-chlor-17alpha-hydroxy-16-methylen-4,6-pregnadien-3,20-dion 17-acetat |
16-methylenechlormadinone |
agelin |
6-chloro-17alpha-hydroxy-16-methylene-4,6-pregnadiene-3,20-dione 17-acetate |
6-chloro-17-hydroxy-16-methylenepregna-4,6-diene-3,20-dione acetate |
[(8r,9s,10r,13s,14s,17r)-17-acetyl-6-chloro-10,13-dimethyl-16-methylidene-3-oxo-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl] acetate |
6799-23-1 |
CHEMBL3276150 |
17-(acetyloxy)-6-chloro-16-methylenepregna-4,6-diene-3,20-dione |
DTXSID00987408 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1150490 | Progestational activity in immature rabbit assessed as proliferation of uterus administered intramuscularly by haematoxylin and eosin staining-based assay | 1976 | Journal of medicinal chemistry, Jun, Volume: 19, Issue:6 | Quantitative structure-activity relationships among steroids. Investigations of the use of steric parameters. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (60.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.90
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.90) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |